CSE Bulletin: Expiry - Cresco Labs Inc - Subordinate Voting Share Purchase Warrants

Cresco Labs Inc - Subordinate Voting Share Purchase Warrants listed on September 24, 2019 will expire on September 24, 2022.

Settlement Terms: All trades September 21 and 22 will settle for cash next day. Trades on September 23 will be for cash same day.

The warrants will be halted at noon and delisted at market close September 23, 2022.

_________________________________

Les bons de souscription de Cresco Labs Inc - Subordinate Voting Share Purchase Warrants cotés le 24 septembre 2019 expireront le 24 septembre 2022.

Conditions de règlement : Toutes les transactions des 21 et 22 septembre seront réglées en espèces le jour suivant. Les transactions du 23 septembre se feront en espèces le jour même.

Les bons de souscription seront arrêtés à midi et retirés de la cote à la clôture du marché le 23 septembre 2022.

Delist Date/Date de Retrait: Le 23 septembre/September 2022
Symbol/Symbole: CL.WT

 

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com.

Si vous avez des questions ou si vous avez besoin d'informations supplémentaires, veuillez contacter
le service des inscriptions au 416 367-7340 ou par courriel à l'adresse: Listings@thecse.com.

News Provided by Newsfile via QuoteMedia

CL:CNX,CRLBF
The Conversation (0)
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...

Latest Press Releases

Related News